The NORCOR statin project was initiated in 2017 and is currently headed by MD, PhD John Munkhaugen (clinical part) and Cand Pharm, PhD Nils Tore Vethe (pharmacological part). The project has developed novel methods for direct measurement of statins and primary metabolites in blood and muscle tissue. The methods are used to study statin-effects, muscle effects, and drug adherence. The overall goal is to develop personalized statin treatment and follow-up care so that patients achieve the best possible effect, few side effects and a reduced risk of cardiovascular disease. The project includes method development studies, observational studies and intervention studies which you can read more about here:
The project has 2 ongoing PhD candidates and a post-doctoral researcher. A new PhD candidate will be recruited in 2021.